PHAL On Other Exchanges
text size: T | T
Back to Snapshot
Company Description

Contact Info

Scheelevägen 2

Medicon Village

Lund, 223 81


Phone: 46 46 13 27 78

Fax: 46 46 13 27 79

PharmaLundensis AB (publ) operates as a pharmaceutical company in Sweden. It is conducting a clinical trial for the treatment of chronic obstructive pulmonary disease, a severe lung disease; and completed a clinical study for the treatment of chronic fatigue syndrome. The company was founded in 2006 and is based in Lund, Sweden.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

PHAL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PHAL.
View Industry Companies

Industry Analysis


Industry Average

Valuation PHAL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 3.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PHARMALUNDENSIS AB, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at